During Thursday’s current trade, Netflix, Inc. (NASDAQ:NFLX)’s shares surged 14.69% to $543.31, hitting its highest level today.
Netflix, has released its first-quarter 2015 financial results by posting them to its website http://ir.netflix.com.
On the other hand, NFLX will premiere across all its territories in 2019 in partnership with Silverback Films and WWF, Our Planet, an astonishing new eight part natural history series made by the creators of the critically and popularly acclaimed series Planet Earth.
The ambitious four year project — the largest of its kind ever attempted — will take viewers into never-before-filmed wilderness areas from the ice caps and deep ocean to deserts and remote forests, introducing them to the most precious species and places that must withstand the influence of humanity so generations to come can enjoy the bounties of the natural world. Using the latest in 4K camera technology, the series and a range of specially produced storytelling for multi-media platforms will bring millions of people into intimate contact with some of the world’s rarest animals and most precious natural habitats.
The series is being produced by Silverback Films, led by Alastair Fothergill and Keith Scholey , who created Planet Earth, Frozen Planet and Blue Planet for the BBC, in addition to the Disneynature films Earth, Bears, African Cats and Chimpanzee. WWF, the world’s leading conservation organization with operations in more than 100 countries and over 5 million members, is providing the Silverback team unparalleled access to its projects in protected areas around the world and will collaborate on multi-media storytelling across its web and other platforms.
Netflix, Inc., an Internet television network, engages in the Internet delivery of TV shows and movies directly on TVs, computers, and mobile devices in the United States and internationally. The company operates in three segments: Domestic Streaming, International Streaming, and Domestic DVD. It also provides DVDs-by-mail membership services.
During an early morning trade, Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM)’s shares skyrocketed 39.34% to $1.6999.
Biostar Pharmaceuticals, declared its results of operations for the full year and the quarter ended December 31, 2014.
Mr. Ronghua Wang, Chairman and CEO of Biostar Pharmaceuticals, Inc. commented: “In 2014, we practiced double digit growth in both our top line and gross profit. We believe our positive results are the fruits of labor from our loyal and practiced team at Biostar. By hitting 16.5% growth in sales, we were able to achieve and exceed our internal sales targets. Despite certain write-offs and one off dispositions, we were able to achieve net profit margins of 7.89%. We believe the Company has returned to normal sustainable profit margins after weathering the storm in 2012 that adversely affected our entire industry. We do believe through market research and input from our customers, vendors, industry experts, we were able to adapt to the market by, among other things, developing and introducing several new products to the market. We also executed on a new sales strategy which comprised of rolling out revised incentive compensation structure for our sales team and sales channels.”
“In 2015, the Company will continually re-examine its product portfolio to focus on high margin products and expand its national sales footprint. The Company will look to grow sales for its products via e-commerce. Of course, the Company will not remain static with its core competency the research and development of new drugs. The Company also believes that economies of scale is vital to continue to improve its bottom line; accordingly, when the right opportunity presents itself, the Company will consider acquiring competitors to ramp up its production.” In closing, Chairman Wang noted: “We will make every effort to make 2015 a banner year so that we can bring superior returns to all of our stakeholders.”
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People’s Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for the treatment of chronic hepatitis B.
MediciNova Inc. (NASDAQ:MNOV), during its Thursday’s current trading session jumped nearly 62.39%, to $5.74, hitting its highest level today.
MediciNova, declared that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for MN-001 (tipelukast) for the treatment of patients with nonalcoholic steatohepatitis (NASH) with fibrosis. Fast Track is a process designed to facilitate the development and expedite the review of drugs that are intended to treat serious or life-threatening diseases and demonstrate the potential to address unmet medical needs for such diseases. An important feature of the FDA’s Fast Track program is that it emphasizes frequent communication between the FDA and the sponsor throughout the entire drug development and review process to improve the efficiency of product development. Accordingly, Fast Track status can potentially lead to a shortened timeline to ultimate drug approval.
In January 2015, MediciNova declared an open Investigational New Drug (IND) application for MN-001 in NASH. Importantly, due to safety data from previous clinical studies of MN-001, FDA has agreed that MediciNova may proceed with a Phase 2 study as the first clinical study of MN-001 in NASH.
MediciNova, Inc., a biopharmaceutical company, focuses on acquiring and developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs for the United States market.
Finally, Identiv, Inc. (NASDAQ:INVE), gained 32.32% Thursday.
INVE declared that it has reached a contract with Cisco Systems Inc. (CSCO) to provide solutions for the Internet of Everything (IoE). The IoE is the intelligent connection of people, processes, data and things to the Internet, bringing unprecedented economic opportunities to both the private and public sectors. Initially, Identiv will deliver a next-generation, networked physical access control system (PACS) solution that interacts with other IoE elements, such as Cisco virtual supervisor module (VSM) cameras and Cisco voice-over-IP (VoIP) telephony products.
Identiv will offer a completely network based access control system, counting credentials, advanced networked uTrust TS door sensors, Power-over-Ethernet (PoE) door controllers and access control software. Identiv is committed to disrupting the traditional physical access market by offering a fully network-based solution that is easy to buy and use. Customers will gain improved value, lower installation costs and less complexity by using standards-based network cabling, leading to reduced total cost of ownership (TCO) and improved return on investment (ROI).
Identiv, Inc. operates as a security technology company that provides solutions in the premises, information, and everyday items. It operates through four segments: Premises, Identity, Credentials, and All Other. The Premises segment offers modular uTrust MX controllers that allows customers to start with a small system and expand over time; uTrust Velocity software platform for centralized administration of access and security operations across an organization; uTrust door readers that provide features to support various security environments and standards; and uTrust TS readers, which support legacy card credentials with next-generation platform.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
